Answer
Anakinra’s terminal half-life after subcutaneous administration at clinically relevant doses of 1–2 mg/kg in patients with rheumatoid arthritis ranged from 4 to 6 hours.
Sources for this answer
- Kineret 100 mg solution for injection in a pre-filled syringeSwedish Orphan Biovitrum Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 20Document updated
Sources checked